Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Cognizant boosts forecast again after healthy quarter

Published 08/05/2015, 12:06 PM
Updated 08/05/2015, 12:06 PM
Cognizant boosts forecast again after healthy quarter

By Abhirup Roy

(Reuters) - IT services provider Cognizant Technology Solutions (NASDAQ:CTSH) Corp reported stronger-than-expected quarterly revenue and profit, as its business that serves the healthcare industry led the company's growth for the third quarter in a row.

Like its Indian rivals Tata Consultancy Services, and Infosys Ltd, New Jersey-based Cognizant gets the largest chunk of its revenue from financial services clients.

But its division that helps health insurers, drug companies, and other health-related businesses streamline their operations is its fastest-growing.

Cognizant said in May it expected healthcare to drive growth this year, helped by its $2.7 billion acquisition of U.S. healthcare IT services provider TriZetto Corp and the implementation of the U.S. Affordable Care Act, or Obamacare.

Shares of Cognizant, which also raised its full-year revenue and adjusted profit forecasts for the second time this year, rose as much as 9.6 percent in early trading on Wednesday.

Revenue from Cognizant's healthcare clients surged 39 percent to $897.3 million in the second quarter ended June 30, while revenue from its core financial clients rose 18.1 percent to $1.25 billion.

The company's healthcare business accounted for 29.1 percent of revenue in the quarter, compared with 25.6 percent in the same quarter of 2014.

An unprecedented wave of M&A activity among health insurers has created some uncertainty for Cognizant, however.

On one hand, merged companies may need help to integrate their systems. On the other, there are fewer companies with which to do business.

Cognizant said on Wednesday it did not expect a 7-year deal it signed with health insurer Health Net Inc last year to be implemented after the company agreed to be bought by larger rival Centene Corp.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Chief Executive Francisco D'Souza said it was unclear in the short term how other deals would affect his company.

"We have been appropriately prudent as we have given our guidance to account for that," he told Reuters.

Cognizant raised its forecast for full-year adjusted profit to at least $3.00 per share from $2.93 and its forecast for revenue to at least $12.33 billion, from $12.24 billion.

Analysts on average expected a profit $2.97 per share and revenue of $12.32 billion, according to Thomson Reuters I/B/E/S.

Revenue rose 22.6 percent to $3.09 billion. Excluding items, Cognizant earned 79 cents per share. Analysts on average had expected 73 cents per share and revenue of $3.03 billion.

Up to Tuesday's close, the stock had risen more than 20 percent in the past 12 months.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.